Does Metformin Reduce Risk for Death in COVID 19
Does Metformin Reduce Risk for Death in COVID-19? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 14, 2020 Category: General Medicine Source Type: news
A rare case of metformin intoxication with mortal course - Osoydan Satici M, Algin A, Aksel G, Ero ğlu SE.
Metformin-associated lactic acidosis is a rare side effect in metformin poisoning. There is conflicting data about mortality rates changing from 3% to 83%. We aimed to discuss a case that developed lactic acidosis and acute renal failure progressing to mor... (Source: SafetyLit)
Source: SafetyLit - August 4, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Dapagliflozin as add-on to metformin may reduce T2DM burden in China
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 31, 2020 Category: Drugs & Pharmacology Source Type: news
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market
As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 4,92,858 bottles of Metformin Hydrochloride extended-release tablets in 500 mg and 1,000 strengths. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 25, 2020 Category: Pharmaceuticals Source Type: news
Search list of recalled metformin products
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 13, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA, additional analysis revealed that certain tested batches wer (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 8, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Lupin recalls diabetes treatment drug in US
Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 7, 2020 Category: Pharmaceuticals Source Type: news
Granules Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Granules Pharmaceuticals, Inc., Chantilly, VA is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of NNitrosodimethylamine (NDMA) levels above the Acceptable Dail (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 6, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Is Metformin the Best Therapy for Diabetes?
Is Metformin the Best First-Line Therapy for Those With Diabetes? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 30, 2020 Category: General Medicine Source Type: news
' Right Diabetes Med for the Right Patient for the Right Outcome'' Right Diabetes Med for the Right Patient for the Right Outcome '
A network meta-analysis of more than 400 trials of 21 drugs for type 2 diabetes sheds light on outcomes in patients who were drug-naive or on metformin and at low or high risk of cardiovascular disease.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 29, 2020 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
Is Metformin the Best First-Line Therapy for Those With Diabetes? Is Metformin the Best First-Line Therapy for Those With Diabetes?
A network meta-analysis of more than 400 trials of 21 drugs for type 2 diabetes sheds light on outcomes in patients who were drug-naive or on metformin and at low or high risk of cardiovascular disease.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 29, 2020 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
Diabetes Drug May Lower COVID-19 Death Risk in Women Diabetes Drug May Lower COVID-19 Death Risk in Women
Women taking the widely used oral diabetes medication metformin may be at lower risk for fatal COVID-19, according to a study that has not yet been peer-reviewed.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 24, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
DPPOS at 22 Years:'Diabetes Prevention Is Possible' Long Term DPPOS at 22 Years:'Diabetes Prevention Is Possible' Long Term
' Even after 22 years, adults at a high risk for [type 2] diabetes have continued to benefit from metformin, or prior intensive lifestyle modification, in preventing or delaying ' disease development.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 24, 2020 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
Common medication may protect diabetic women from coronavirus
In one of the world's largest coronavirus studies to-date, University of Minnesota researchers found that metformin may stem inflammation for diabetic and obese women to lower their death risks. (Source: the Mail online | Health)
Source: the Mail online | Health - June 24, 2020 Category: Consumer Health News Source Type: news
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of One Lot of Metformin Hydrochloride Extended-Release Tablets USP, 500mg Due to the Detection of N-Nitrosodimethylamine (NDMA)
Lupin Pharmaceuticals Inc. is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets USP (generic equivalent of Fortamet ®), 500mg, lot G901203 to the consumer level. FDA analysis revealed that this lot exceeded the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 13, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
